RoosterBio Inc and Tissue Regeneration Therapeutics Inc Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology December 10, 2018
RoosterBio Submits U.S. FDA Master Files for CliniControl Line of Human Mesenchymal Stem/Stromal Cell Products. November 9, 2018
RoosterBio Inc. Earns NIIMBL NOD With 2 Grant Awards for Regenerative Medicine Manufacturing. October 11, 2018
RoosterBio Inc. Becomes Industry Partner in NSF-Funded Public-Private Cell Manufacturing Technologies Initiative. June 13, 2018
RoosterBio Commercializes Industry’s First cGMP human Mesenchymal Stem Cell Banks for Widespread Manufacturing, Continuing to Revolutionize Regenerative Medicine. January 25, 2018
RoosterBio selects GenCure as its preferred manufacturer to leverage its scalable technology platform, accelerating the initiation of first-in-man studies. October 2, 2017
RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry. September 14, 2017
